Vivos Therapeutics (VVOS) Non-Current Debt (2020 - 2026)
Vivos Therapeutics' (VVOS) quarterly Non-Current Debt came in at $366000.0 in Q2 2026, down 95.28% year-over-year from $7.8 million in Q2 2025, and down 12.44% quarter-over-quarter from $418000.0 in Q1 2026.
Powered by 
Analysis
Vivos Therapeutics (VVOS) Non-Current Debt (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Non-Current Debt for 4 consecutive years, with $366000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Debt fell 95.28% year-over-year to $366000.0 in Q2 2026; TTM through Jun 2026 was $366000.0, a 95.28% decrease from a year earlier, with the FY2025 full-year figure at $469000.0, changed N/A from the prior year.
- Non-Current Debt was $366000.0 for Q2 2026 at Vivos Therapeutics, down from $418000.0 in the prior quarter.
- Over five years, Non-Current Debt peaked at $8.4 million in Q3 2025 and troughed at $366000.0 in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn | - |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | 1.44 Bn |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn | 2.00 Bn |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn | - |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | - |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn | 366,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 366,000.00 |
| Mar 31, 2026 | 418,000.00 |
| Dec 31, 2025 | 469,000.00 |
| Sep 30, 2025 | 8.38 Mn |
| Jun 30, 2025 | 7.76 Mn |
| Sep 30, 2021 | 1.27 Mn |
| Jun 30, 2021 | 1.27 Mn |
| Mar 31, 2021 | 105,906.00 |
| Dec 31, 2020 | 423,000.00 |